As per this study, the Global Human Milk Oligosaccharides (HMO) Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2027 with a CAGR of XX%.
The human milk oligosaccharides or HMO are the complex carbohydrates mainly found in human milk. HMOs is beneficial for microbiome and enhance the immunity. HMO is basically used in the production of infant formula, functional food & beverages, and food supplements. Additionally, it helps to prevent individuals from various disease such as cardiovascular diseases, type 1 diabetes, and infectious diseases.
The increasing awareness regarding HMOs and its benefits of improving immunity and bacterial growth which are essential to human body are driving the market growth. Growing applications and product line in functional food is another factor accelerating the demand for HMOs. Additionally, growing R&D for extraction of HMO with new techniques is also expected to boost the market growth. On the other hand, high production cost associated with HMOs and availability of substitutes such as galactooligosaccharides and fructooligosaccharides may hamper the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of human milk oligosaccharides (HMO).
The broad human milk oligosaccharides (HMO) market has been sub-grouped into product and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- 2’-Fucosyllactose (2’FL)
- 3’-Fucosyllactose (3’FL)
- 3’-Sialyllactose (3’SL)
- 6’-Sialyllactose (6’SL)
- Lacto-N-tetraose (LNT)
- Lacto-N-neotetraose (LNnT)
- Infant Formula
- Functional Food & Beverages
- Food Supplements
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for human milk oligosaccharides (HMO) in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Human Milk Oligosaccharides (HMO) Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the human milk oligosaccharides (HMO) market includes Elicityl S.A., Glycom A/S , Glycosyn LLC, Inbiose NV, Jennewein Biotechnologie GmbH, Medolac Laboratories and ZuChem Inc.. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.